Last updated on June 2019

Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden


Brief description of study

The purpose of this study is to determine whether FG-4592 is safe and effective in the treatment of anemia in patients with Lower Risk Myelodysplastic Syndrome and Low Red Blood Cell Transfusion Burden.

Detailed Study Description

This study includes an Open-Label and a Double-Blind component. In each, there is an up to 28 days screen period followed by a treatment period of 52 weeks and a 4 week end of treatment assessment.

Clinical Study Identifier: NCT03263091

Find a site near you

Start Over

Investigational Site

Alhambra, CA United States
  Connect »

Investigational Site

Bakersfield, CA United States
  Connect »

Investigational Site

Beverly Hills, CA United States
  Connect »

Investigational Site

Burbank, CA United States
  Connect »

Investigational Site

Encino, CA United States
  Connect »

Investigational Site

Irvine, CA United States
  Connect »

Investigational Site

Laguna Hills, CA United States
  Connect »

Investigational Site

Los Angeles, CA United States
  Connect »

Investigational Site

Oceanside, CA United States
  Connect »

Investigational Site

Pasadena, CA United States
  Connect »

Investigational Site

Santa Maria, CA United States
  Connect »

Investigational Site

Santa Rosa, CA United States
  Connect »

Investigational Site

Torrance, CA United States
  Connect »

Investigational Site

Valencia, CA United States
  Connect »

Investigational Site

Ventura, CA United States
  Connect »

Investigational Site

Westlake Village, CA United States
  Connect »

Investigational Site

Whittier, CA United States
  Connect »

Investigational Site

Pembroke Pines, FL United States
  Connect »

Investigational Site

Saint Louis, MO United States
  Connect »

Investigational Site

Canton, OH United States
  Connect »

Investigational Site

Cleveland, OH United States
  Connect »

Investigational Site

Mayfield Heights, OH United States
  Connect »

Investigational Site

Philadelphia, PA United States
  Connect »

Investigational Site

Houston, TX United States
  Connect »

Investigational Site

Darlinghurst, Australia
  Connect »

Investigational Site

South Brisbane, Australia
  Connect »

Investigational Site

Victoria Park, Australia
  Connect »

Investigational Site

Incheon, Korea, Republic of
  Connect »

Investigational Site

Hwasun, Korea, Republic of
  Connect »

Investigational Site

Seoul, Korea, Republic of
  Connect »

Investigational Site

Kaluga, Russian Federation
  Connect »

Investigational Site

Moscow, Russian Federation
  Connect »

Investigational Site

Omsk, Russian Federation
  Connect »

Investigational Site

Saint Petersburg, Russian Federation
  Connect »

Investigational Site

Boston, United Kingdom
  Connect »

Investigational Site

Harrow, United Kingdom
  Connect »

Investigational Site

London, United Kingdom
  Connect »

Investigational Site

Manchester, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.